Bronchoconstrictor effects of leukotriene E4 in normal and asthmatic subjects.
Bronchoconstrictor effects of leukotriene E4 in normal and asthmatic subjects.
复制标题
白三烯 E4 对正常和哮喘受试者的支气管收缩作用。
DOI:
10.1164/arrd.1987.135.2.333
复制
发表时间:
1987
期刊:
影响因子:
--
通讯作者:
Drazen,JM
中科院分区:
文献类型:
--
作者:
Davidson,AB;Lee,TH;Scanlon,PD;Solway,J;McFaddenJr,ER;IngramJr,RH;Corey,EJ;Austen,KF;Drazen,JM
The bronchoconstrictor activity of an aerosol of leukotriene E4(LTE4) was compared with that of histamine in 5 normal and in 6 asthmatic subjects to define the relative potency of LTE4between the groups using 3 indices of airway response. The FEV1and the flow rate measured at 30% of vital capacity from partial and maximal expiratory maneuvers ( and ) were measured. The geometric mean (GSEM) concentration of LTE4required to reduce the by 30% was 0.30(1.46) mM in the normal subjects, and 0.058 (1.63) in the asthmatic subjects; LTE4was 39-fold more potent than histamine in the former and 14-fold in the latter group. Further, we observed that when normal and asthmatic subjects were compared at a degree of bronchoconstriction resulting in a 30% decrement in the after inhaling LTE4, there was a greater response in the asthmatic group than in the normal group of the accompanying change in the FEV1.The decrements in the FEV1were not significantly different between the 2 groups after inhaling histamine. This study demonstrates that LTE4is a potent bronchoconstrictor agonist in humans and suggests that airway responsiveness to this agonist differs substantially with the index of bronchoconstriction used for assessment Of airway response.